Evidence map›Paper›PMID 33654798›Full record

ArticleBio-protocol2019

Detection of Heteroplasmic Variants in the Mitochondrial Genome through Massive Parallel Sequencing.

Joke Mertens, Filippo Zambelli, Dorien Daneels, Ben Caljon, Karen Sermon, Claudia Spits

Abstract read
In one paragraph

Article in Bio-protocol, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joke MertensResearch Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussel, Belgium.
Filippo ZambelliClinica Eugin, Barcelona, Spain.
Dorien DaneelsCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
Ben CaljonCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
Karen SermonResearch Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussel, Belgium.
Claudia SpitsResearch Group Reproduction and Genetics, Vrije Universiteit Brussel, Brussel, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detecting heteroplasmies in the mitochondrial DNA (mtDNA) has been a challenge for many years. In the past, Sanger sequencing was the main option to perform this analysis, however, this method could not detect low frequency heteroplasmies. Massive Parallel Sequencing (MPS) provides the opportunity to study the mtDNA in depth, but a controlled pipeline is necessary to reliably retrieve and quantify the low frequency variants. It has been shown that differences in methods can significantly affect the number and frequency of the retrieved variants. In this protocol, we present a method involving both wet lab and bioinformatics that allows identifying and quantifying single nucleotide variants in the full mtDNA sequence, down to a heteroplasmic load of 1.5%. For this, we set up a PCR-based amplification of the mtDNA, followed by MPS using Illumina chemistry, and variant calling with two different algorithms, mtDNA server and Mutect. The PCR amplification is used to enrich the mitochondrial fraction, while the bioinformatic processing with two algorithms is used to discriminate the true heteroplasmies from background noise. The protocol described here allows for deep sequencing of the mitochondrial DNA in bulk DNA samples as well as single cells (both large cells such as human oocytes, and small-sized single cells such as human embryonic stem cells) with minor modifications to the protocol.

Indexed as

Amplicon sequencingHeteroplasmyLong range PCRMassive parallel sequencingmtDNA

Identifiers

PMID33654798
PMCPMC7854219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.